nach oben

Current Breast Cancer Reports

Erschienen in:

07.08.2018 | Global Breast Cancer (BO Anderson and C Duggan, Section Editors)

Breast Cancer Disparities Among Women in Low- and Middle-Income Countries

verfasst von: O. Ginsburg, A. F. Rositch, L. Conteh, M. Mutebi, E. D. Paskett, S. Subramanian

Erschienen in: Current Breast Cancer Reports | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The burden of breast cancer in low-income and middle-income countries transitioning to higher levels of human development is a public health crisis, set to increase dramatically in the coming decades. This paper provides an overview of the burden in human and economic terms, a summary of the costs, and cost-effective analyses for breast cancer interventions and suggests a way forward through research to better inform national, regional, and global policies for breast cancer control.

Recent Findings

Inequitable access to effective health services for breast cancer is striking between and within countries, where much of the costs are shouldered through out-of-pocket expenditures. A variety of factors can influence opportunities for women with breast symptoms to seek care and to access effective and affordable early detection and treatment services.

Summary

Research into disparities and solutions to overcome these, including an evidence-informed investment case for breast cancer control, can help to garner the necessary political will and sustained commitments to ensure adequate and sustainable resources are available to reduce disparities in breast cancer survival.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRefPubMed

Ferlay, JSI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase no. 11 [internet]. 2012. Accessed April 10, 2018.

Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6(6):229–39.CrossRefPubMedPubMedCentral

Anderson BO. Breast cancer—thinking globally. Science. 2014;343(6178):1403.CrossRefPubMed

Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women's cancers: a grand challenge in global health. Lancet (London, England). 2017;389(10071):847–60.CrossRef

Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 2010;376:1186–93.CrossRefPubMed

Fidler MM, Soerjomataram I, Bray F. A global view on cancer incidence and national levels of the human development index. Int J Cancer. 2016;139(11):2436–46.CrossRefPubMed

Yip CH, Buccimazza I, Hartman M, Deo SV, Cheung PS. Improving outcomes in breast cancer for low and middle income countries. World J Surg. 2015;39(3):686–92.CrossRefPubMed

McKenzie F, Zietsman A, Galukande M, Anele A, Adisa C, Parham G, et al. Drivers of advanced stage at breast cancer diagnosis in the multicountry African breast cancer - disparities in outcomes (ABC-DO) study. Int J Cancer. 2018;142(8):1568–79.CrossRefPubMed

10.

Espina C, McKenzie F, Dos-Santos-Silva I. Delayed presentation and diagnosis of breast cancer in African women: a systematic review. Ann Epidemiol. 2017;27(10):659–671.e657.CrossRefPubMedPubMedCentral

11.

Jedy-Agba E, McCormack V, Adebamowo C, Dos-Santos-Silva I. Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2016;4(12):e923–35.CrossRefPubMedPubMedCentral

12.

Cancer in Africa. American Cancer Society;2011.

13.

Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol. 2009;33(5):315–8.CrossRefPubMed

14.

Unger-Saldana K. Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol. 2014;5(3):465–77.CrossRefPubMedPubMedCentral

15.

Chapter 2. The role and status of population-based cancer registration. https://www.iarc.fr/en/publications/pdfs-online/treport-pub/treport-pub43/IARC_Technical_Report_No43.pdf2013.

16.

Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet (London, England). 2018;391(10125):1023–75.CrossRefPubMed

17.

Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global Cancer in women: burden and trends. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology. 2017;26(4):444–57.

18.

Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119e25.

19.

WHO Guide to Cancer Early Diagnosis. World Health Organization, 2017. http://apps.who.int/iris/bitstream/handle/10665/254500/9789241511940-eng.pdf;jsessionid=7880E9D0843877E28678CF8138140412?sequence=1. Accessed April 21st 2018.

20.

Pace LE, Mpunga T, Hategekimana V, Dusengimana JMV, Habineza H, Bigirimana JB, et al. Delays in breast Cancer presentation and diagnosis at two rural Cancer referral centers in Rwanda. Oncologist. 2015;20(7):780–8. https://doi.org/10.1634/theoncologist.2014-0493.CrossRefPubMedPubMedCentral

21.

Sharma K, Costas A, Shulman LN, Meara JG. A systematic review of barriers to breast Cancer Care in Developing Countries Resulting in delayed patient presentation. J Oncol. 2012;2012:121873. https://doi.org/10.1155/2012/121873.CrossRefPubMedPubMedCentral

22.

Bollyky TJ, Templin T, Cohen M, Dieleman JL. Lower-income countries that face the most rapid shift in noncommunicable disease burden are also the least prepared. Health Aff (Millwood). 2017;36(11):1866–75. https://doi.org/10.1377/hlthaff.2017.0708. www.ncbi.nlm.nih.gov/pubmed/29137514 CrossRef

23.

Sullivan R, Alatase OI, Anderson BO, et al. Global Cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015;16(11):1193–224.CrossRefPubMed

24.

Wilson L, Fleming A, Kuti M, Loo LM, et al. Access to pathology and laboratory medicine services: a crucial gap. Lancet commission on pathology and lab services. Lancet. 2018;391:1927–38. https://doi.org/10.1016/S0140-6736(18)30458-6.CrossRefPubMed

25.

Aju M. Global survey of clinical oncology workforce. J Global Oncol. 2018;4:1. https://doi.org/10.1200/JGO.17.00188. Accessed June 30, 2018CrossRef

26.

Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, et al. Expanding global access to radiotherapy. Lancet Oncol. 2015;16:1153–86.CrossRefPubMed

27.

Abdel-Wahab M, Bourque JM, Pynda Y, Izewska J, Van der Merwe D, Zubizarreta E, et al. Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol. 2013;14:e168–75.CrossRefPubMed

28.

Crisp N, Gawanas B. Training the health workforce. Scaling up, saving lives. Lancet. 2008;371:689–91.CrossRefPubMed

29.

Crisp N, Chen L. Global survey of health professionals. N Engl J Med. 2014;370:950–7.CrossRefPubMed

30.

Tetteh D, Faulkner FL. Sociocultural factors and breast cancer in sub-Saharan Africa: implications for diagnosis and management. Womens Health. 2016;12(1):147–56.

31.

Price AJ, Ndom P, Atenguena E, Nouemssi JPM, Ryder RW. Cancer care challenges in developing countries. Cancer. 2011;118(14):3627–35.CrossRefPubMed

32.

Muthoni A, Miller AN. An exploration of rural and urban Kenyan women’s knowledge and attitudes regarding breast cancer and breast cancer early detection measures. Health Care Women Int. 2010;31(9):801–16. https://doi.org/10.1080/07399331003628453.CrossRefPubMed

33.

Morse EP, Maegga B, Joseph G, Miesfeldt S. Breast Cancer knowledge, beliefs, and screening practices among women seeking Care at District Hospitals in Dar es salaam, Tanzania. Breast Cancer. 2014;8:73–9. https://doi.org/10.4137/BCBCR.S13745.PubMedCrossRef

34.

Story HL, Love RR, Salim RR, Roberto AJ, Krieger JL, Ginsburg O. Improving outcomes from breast cancer in a low-income country: lessons from Bangladesh. Int J Breast Cancer. 2012;2012:1–9.CrossRef

35.

Alqaissi NM, Dickerson SS. Exploring common meanings of social support as experienced by Jordanian women with breast cancer. Cancer Nurs. 2010;33(5):353–61.CrossRefPubMed

36.

Banning M, Hafeez H, Faisal S, Hassan M, Zafar A. The impact of culture and sociological and psychological issues on Muslim patients with breast cancer in Pakistan. Cancer Nurs. 2009;32(4):317–24.CrossRefPubMed

37.

Nyblade L, Stockton M, Travasso S, Krishnan S. A qualitative exploration of cervical and breast cancer stigma in Karnataka, India. BMC Womens Health. 2017:58. https://doi.org/10.1186/s12905-017-0407-x.

38.

Sathwara JA, Balasubramaniam G, Bobdey SC, Jain A, Saoba S. Sociodemographic factors and late-stage diagnosis of breast Cancer in India: a hospital-based study. Indian J Med Paediatr Oncol. 2017;38(3):277–81. https://doi.org/10.4103/ijmpo.ijmpo_15_16.

39.

Asobayire A, Barley R. Women's cultural perceptions and attitudes towards breast cancer: northern Ghana. Health Promot Int. 2015;30(3):647–57.CrossRefPubMed

40.

Zelle SG, Nyarko KM, Bosu WK, Aikins M, Niëns LM, Lauer JA, et al. Costs, effects and cost-effectiveness of breast cancer control in Ghana. Tropical Med Int Health. 2012;17:1031–43. https://doi.org/10.1111/j.1365-3156.2012.03021.x. CrossRef

41.

Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst. 2008;100(18):1290–300.CrossRefPubMed

42.

Nguyen LH, Laohasiriwong W, Stewart JF, Wright P, Nguyen YTB, et al. Cost-effectiveness analysis of a screening program for breast Cancer in Vietnam. Value Health Reg Issues. 2013;2(1):21–8.CrossRefPubMed

43.

Niëns LM, Zelle SG, Gutiérrez-Delgado C, Rivera Peña G, Hidalgo Balarezo BR, Rodriguez Steller E, et al. Cost-effectiveness of breast cancer control strategies in central America: the cases of Costa Rica and Mexico. PLoS One. 2014;9(4):e95836. https://doi.org/10.1371/journal.pone.0095836. eCollection 2014CrossRefPubMedPubMedCentral

44.

Groot MT, Baltussen R, Uyl-de Groot CA, Anderson BO, Hortobágyi GN. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. Breast J. 2006;12(Suppl 1):S81–90.CrossRefPubMed

45.

Ginsberg GM, Lauer JA, Zelle S, Baeten S, Baltussen R. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ. 2012;344:e614. https://doi.org/10.1136/bmj.e614.CrossRefPubMedPubMedCentral

46.

Valencia-Mendoza A, Sánchez-González G, Bautista-Arredondo S, Torres-Mejía G, Bertozzi SM. Costo-efectividad de políticas para el tamizaje de cáncer de mama en México. Salud pública Méx. 2009;51(l.2):S296–s304.CrossRefPubMed

47.

Salomon JA, Carvalho N, Gutiérrez-Delgado C, Orozco R, Mancuso A. Others. Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis. Br Med J. 2012;344:e355.CrossRef

48.

Zelle SG, Vidaurre T, Abugattas JE, Manrique JE, Sarria G, Jeronimo J, et al. Cost-effectiveness analysis of breast cancer control interventions in Peru. PLoS One. 2013;8(12):e82575. https://doi.org/10.1371/journal.pone.0082575. eCollection 2013CrossRefPubMedPubMedCentral

49.

Denewer A, Hussein O, Farouk O, Elnahas W, Khater A, El-Saed A. Cost-effectiveness of clinical breast assessment-based screening in rural Egypt. World J Surg. 2010;34:2204–10.CrossRefPubMed

50.

Zelle SG, Baltussen RM. Economic analyses of breast cancer control in low- and middle-income countries: a systematic review. Syst Rev. 2013;2:20. https://doi.org/10.1186/2046-4053-2-20.

51.

WHO Position Paper on Mammography Screening, World Health Organization 2014. http://apps.who.int/iris/bitstream/handle/10665/137339/9789241507936_eng.pdf;jsessionid=5643866F9EE770D876A5212EFF87F633?sequence=1.

52.

Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P, et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst. 2011;103(19):1476–80. https://doi.org/10.1093/jnci/djr304.CrossRefPubMed

53.

Pisani P, Parkin DM, Ngelangel C, Esteban D, Gibson L, Munson M, et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer. 2006;118(1):149–54.CrossRefPubMed

54.

Kardinah D, Anderson BO, Duggan C, Ali IA, Thomas DB. Short report: limited effectiveness of screening mammography in addition to clinical breast examination by trained nurse midwives in rural Jakarta, Indonesia. Int J Cancer. 2014;134(5):1250–5. https://doi.org/10.1002/ijc.28442.CrossRefPubMed

55.

IARC Handbooks of Cancer Prevention Volume 15: Breast Cancer Screening International Agency for Research on Cancer, Lyon; 2016.

56.

Best buys and other recommendations for the prevention and control of noncommunicable diseases. World Health Organization; 2017. http://apps.who.int/iris/bitstream/handle/10665/259232/WHO-NMH-NVI-17.9-eng.pdf;jsessionid=9369D56B573278B3D15C97A64E868EB4?sequence=1. Date accessed April 22nd, 2018.

57.

Dvaladze A, Duggan C, Gralow JR, Anderson BO. Phased implementation model of resource-stratified guidelines for breast Cancer control. J Global Oncol. 2017;3(2_suppl):17s.CrossRef

58.

Horton S, Gauvreau CL. Cancer in low- and middle-income countries: an economic overview. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, vol. 3. 3rd ed. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015. Chapter 16.

59.

Anderson BO, Ilbawi AM, El Saghir NS. Breast cancer in low and middle income countries (LMICs): a shifting tide in global health. Breast J. 2015 Jan-Feb;21(1):111–8. https://doi.org/10.1111/tbj.12357.CrossRefPubMed

60.

Subramanian S, Gakunga R, Kibachio J, Gathecha G, Edwards P, Ogola E, et al. Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors. PLoS One. 2018; https://doi.org/10.1371/journal.pone.0190113.

61.

Rajpal S, Kumar A, Joe W. Economic burden of cancer in India: evidence from cross-sectional nationally representative household survey, 2014. PLoS One. 2018;13(2):e0193320. https://doi.org/10.1371/journal.pone.0193320. eCollection 2018CrossRefPubMedPubMedCentral

62.

Chisolm D. Economic impact of disease and injury: counting what matters. BMJ. 2010;340:c924. https://doi.org/10.1136/bmj.c924.CrossRef

63.

Glover M, Buxton M, Guthrie S, Hanney S, Pollitt A, Grant J. Estimating the returns to the UK publicly funded cancer-related research in terms of the net value of improved health outcomes. BMC Med. 2014;12:99. https://doi.org/10.1186/1741-7015-12-99. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058434/CrossRefPubMedPubMedCentral

64.

Pakseresht S, Ingle GK, Garg S, Singh MM. Expenditure audit of women with breast cancer in a tertiary care hospital of Delhi. Indian J Cancer. 2011;48:428–37.CrossRefPubMed

65.

Hoang Lan N, Laohasiriwong W, Stewart JF, Tung ND, Coyte PC. Cost of treatment for breast cancer in Central Vietnam. Glob Health Action. 2013;6:18872.CrossRefPubMed

66.

Woodward M, Kimman M, Jan S, Mejri AA. The economic cost of cancer to patients and their families in Southeast Asia. Asia Pac J Clin Oncol. 2014;10:43.

67.

Langer A, Meleis A, Knaul FM, Atun R, Aran M, Arreola-Ornelas H, et al. Women and health: the key for sustainable development. Lancet. 2015;386:1165–210.CrossRefPubMed

68.

Ekwueme DU, Guy GP Jr, Rim SH, White A, Hall IJ, Fairley TL, et al. Health and economic impact of breast Cancer mortality in young women, 1970–2008. Am J Prev Med. 2014;46(1):71–9. https://doi.org/10.1016/j.amepre.2013.08.016.CrossRefPubMedPubMedCentral

69.

Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomark Prev. 2011;20(10):2006–14. https://doi.org/10.1158/1055-9965.EPI-11-0650.CrossRef

70.

Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol. 2013;14(12):1165–74. https://doi.org/10.1016/S1470-2045(13)70442-X.CrossRefPubMed

71.

Daroudi R, Akbari Sari A, Nahvijou A, Kalaghchi B, Najafi M, Zendehdel K. The economic burden of breast Cancer in Iran. Iran J Public Health. 2015;44(9):1225–33.PubMedPubMedCentral

72.

Fletcher-Brown J. Confronting breast cancer is crucial to India’s economic development. The conversation. 2017. http://theconversation.com/confronting-breast-cancer-is-crucial-to-indias-economic-development-81717. Accessed 17 Apr 2018.

73.

Chalker L, et al. The global impact of non-communicable diseases on macro-economic productivity: a systematic review. Eur J Epidemiol. 2015;30(5):357–95. https://doi.org/10.1007/s10654-015-0026-5.CrossRef

74.

Bertram MY, Sweeny K, Lauer J, et al. Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services. Lancet. 2018; https://doi.org/10.1016/S0140-6736(18)30665-2.

75.

Skrundevskiy AN, Omar OS, Kim J, Soliman AS, Korolchuk TA, Wilson FA. Return on investment analysis of breast Cancer screening and Downstaging in Egypt: implications for developing countries. Value Health Reg Issues. 2018;16:22–7. https://doi.org/10.1016/j.vhri.2018.01.006.CrossRefPubMed

Titel: Breast Cancer Disparities Among Women in Low- and Middle-Income Countries
verfasst von: O. Ginsburg
A. F. Rositch
L. Conteh
M. Mutebi
E. D. Paskett
S. Subramanian
Publikationsdatum: 07.08.2018
Verlag: Springer US
Erschienen in: Current Breast Cancer Reports / Ausgabe 3/2018
Print ISSN: 1943-4588
Elektronische ISSN: 1943-4596
DOI: https://doi.org/10.1007/s12609-018-0286-7

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Breast Cancer Disparities Among Women in Low- and Middle-Income Countries